Mature and immature platelets during the first week after birth and incidence of patent ductus arteriosus.


Journal

Cardiology in the young
ISSN: 1467-1107
Titre abrégé: Cardiol Young
Pays: England
ID NLM: 9200019

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 29 4 2020
medline: 30 3 2021
entrez: 29 4 2020
Statut: ppublish

Résumé

Thrombocytopenia is a risk factor for patent ductus arteriosus. Immature and mature platelets exhibit distinct haemostatic properties; however, whether platelet maturity plays a role in postnatal, ductus arteriosus closure is unknown. In this observational study, counts of immature and mature platelets (=total platelet count - immature platelet count) were assessed on days 1, 3, and 7 of life in very low birth weight infants (<1500 g birth weight). We performed echocardiographic screening for haemodynamically significant patent ductus arteriosus on day 7. Counts of mature platelets did not differ on day 1 in infants with (n = 24) and without (n = 45) haemodynamically significant patent ductus arteriosus, while infants with significant patent ductus arteriosus exhibited lower counts of mature platelet on postnatal days 3 and 7. Relative counts of immature platelets (fraction, in %) were higher in infants with patent ductus arteriosus on day 7 but not on days 1 and 3. Receiver operating characteristic curve analysis unraveled associations between both lower mature platelet counts and higher immature platelet fraction (percentage) values on days 3 and 7, with haemodynamically significant ductus arteriosus. Logistic regression analysis revealed that mature platelet counts, but not immature platelet fraction values, were independent predictors of haemodynamically significant patent ductus arteriosus. During the first week of postnatal life, lower counts of mature platelets and higher immature platelet fraction values are associated with haemodynamically significant patent ductus arteriosus. Lower counts of mature platelet were found to be independent predictors of haemodynamically significant patent ductus arteriosus.

Sections du résumé

BACKGROUND BACKGROUND
Thrombocytopenia is a risk factor for patent ductus arteriosus. Immature and mature platelets exhibit distinct haemostatic properties; however, whether platelet maturity plays a role in postnatal, ductus arteriosus closure is unknown.
METHODS METHODS
In this observational study, counts of immature and mature platelets (=total platelet count - immature platelet count) were assessed on days 1, 3, and 7 of life in very low birth weight infants (<1500 g birth weight). We performed echocardiographic screening for haemodynamically significant patent ductus arteriosus on day 7.
RESULTS RESULTS
Counts of mature platelets did not differ on day 1 in infants with (n = 24) and without (n = 45) haemodynamically significant patent ductus arteriosus, while infants with significant patent ductus arteriosus exhibited lower counts of mature platelet on postnatal days 3 and 7. Relative counts of immature platelets (fraction, in %) were higher in infants with patent ductus arteriosus on day 7 but not on days 1 and 3. Receiver operating characteristic curve analysis unraveled associations between both lower mature platelet counts and higher immature platelet fraction (percentage) values on days 3 and 7, with haemodynamically significant ductus arteriosus. Logistic regression analysis revealed that mature platelet counts, but not immature platelet fraction values, were independent predictors of haemodynamically significant patent ductus arteriosus.
CONCLUSION CONCLUSIONS
During the first week of postnatal life, lower counts of mature platelets and higher immature platelet fraction values are associated with haemodynamically significant patent ductus arteriosus. Lower counts of mature platelet were found to be independent predictors of haemodynamically significant patent ductus arteriosus.

Identifiants

pubmed: 32340633
pii: S1047951120000943
doi: 10.1017/S1047951120000943
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-773

Auteurs

Hannes Sallmon (H)

Department of Pediatric Cardiology, Charité University Medical Center, Berlin, Germany.
Department of Neonatology, Charité University Medical Center, Berlin, Germany.

Boris Metze (B)

Department of Neonatology, Charité University Medical Center, Berlin, Germany.

Petra Koehne (P)

Department of Neonatology, Charité University Medical Center, Berlin, Germany.

Bernd Opgen-Rhein (B)

Department of Pediatric Cardiology, Charité University Medical Center, Berlin, Germany.

Katja Weiss (K)

Department of Pediatric Cardiology, Charité University Medical Center, Berlin, Germany.

Joachim C Will (JC)

Department of Pediatric Cardiology, Charité University Medical Center, Berlin, Germany.

Christina Victoria Franke (CV)

Department of Neonatology, Charité University Medical Center, Berlin, Germany.

Georg Hansmann (G)

Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.

Martin Koestenberger (M)

Division of Pediatric Cardiology, Medical University Graz, Graz, Austria.

Christoph Bührer (C)

Department of Neonatology, Charité University Medical Center, Berlin, Germany.

Felix Berger (F)

Department of Pediatric Cardiology, Charité University Medical Center, Berlin, Germany.
Department of Congenital Heart Disease and Paediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.
Deutsches Zentrum für Herz- und Kreislaufforschung (DZHK), Berlin, Germany.

Sven C Weber (SC)

Department of Pediatric Cardiology, Charité University Medical Center, Berlin, Germany.

Malte Cremer (M)

Department of Neonatology, Charité University Medical Center, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH